Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy
Nilesh Raghunath
Khedkar†
b,
Milind
Sindkhedkar
*a and
Alex
Joseph‡
b
aNovel Drug Discovery & Development, Lupin Research Park, Lupin Ltd., Pune-412115, India. E-mail: milindsindkhedkar@lupin.com
bDepartment of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka-576104, India
First published on 15th October 2024
Abstract
Correction for ‘Computational design, synthesis, and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: a prospective strategy for anticancer therapy’ by Nilesh Raghunath Khedkar et al., RSC Med. Chem., 2024, 15, 1626–1639, https://doi.org/10.1039/D4MD00055B.
The authors regret that the affiliation of one of the authors (Nilesh Raghunath Khedkar) was shown incorrectly in the original manuscript. The corrected affiliation is shown here.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnotes |
| † Research Scholar, Manipal Academy of Higher Education. |
| ‡ Deceased on 19th Dec 2023. |
| This journal is © The Royal Society of Chemistry 2024 |